The information on this page is intended for healthcare professionals. Some of the products and services shown here may not be available in your country or region.

Apr. 25, 2022

Radial Access Class 1, Level of Evidence A in guidance of ACC/AHA/SCAI

Class 1, Level of Evidence A for radial access

Updated guidelines published by the American College of Cardiology (ACC), American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI) gave radial access a Class 1 and Level of Evidence A indication for patients undergoing percutaneous coronary intervention (PCI) for the followings:
・Acute coronary syndrome (ACS)
・Stable ischemic heart disease (SIHD)
・Level of Evidence A
・Procedures and approaches with high quality evidence from more than one randomized control trial (RCT).

Radial access benefits for healthcare professionals

Benefits of radial access are well-established and include:

・Reduction in access-site bleeding and other vascular complications

・Early post-procedure ambulation

・Increased patient comfort and satisfaction

・Potential improved financial and operational outcomes through facilitation of same-day discharge

Radial access benefits for healthcare professionals

Terumo has pioneered radial access for 30 years, providing state-of-the-art products and supporting thousands of healthcare providers with training and education, to bring a radial approach and better outcomes to more patients and hospitals across the globe.

https://tis.terumo.com/products/radifocus_introducer_ii

News Top